Ardent Health (ARDT) Stock Price & Analysis

ARDT price $12.22 +0.29 +2.47%

Ticker
ARDT
Price
$12.22
Change
+0.29 +2.47%
Market cap ?
$1.72B
P/E ?
22.31
Forward P/E ?
12.80
Dividend yield ?
0.00%
Beta ?
0.72
Sector
Healthcare
Industry
Medical - Care Facilities
Stocklytics score
44
Value
77
Quality
38
Growth
18

Stocklytics score rationale: value 77, quality 38, growth 18.

Financials

201520162017201820212022202320242025
202937200021052160003002076000416187500048703960005129687000540948300059660720006324339000

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory…

Fair value

ARDT fair value $13.92. Price $12.22. Price is 12% below fair value.

Above fair value, and more expensive than usual. A larger premium than on 98% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 156.80M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 141.05M. Net debt 1.55B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare ARDT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—0.23—1.60B
2026-08-040.120.181.62B1.59B
2026-05-050.280.181.60B1.58B
2026-03-040.320.351.61B1.63B
2025-11-120.520.421.58B1.55B
2025-08-050.520.301.65B1.63B
2025-05-060.290.211.50B1.50B
2025-02-260.810.501.61B1.50B
2024-11-060.170.301.45B1.45B
2024-08-140.340.301.47B1.46B
2024-06-210.21—1.44B—
2023-12-31-0.05—1.35B—
2023-09-300.15—1.38B—
2023-06-300.23—1.37B—
2023-03-310.03—1.32B—
2018-12-30-0.15—1.09B—
2018-09-300.04—1.09B—
2018-06-30-0.10—989.88M—
2018-03-31-0.10—989.88M—
2017-03-310.03—685.11M—
2015-06-300.12—505.31M—
2015-03-310.12—505.31M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-25LUMSDAINE ALFREDSell3.39K$10.5435.72K
2026-09-25Petrovich Stephen C.Sell788$10.548.31K
2026-09-25Byers David RaynorSell524$10.545.52K
2026-07-01Caspers DaveBuy103.65K——
2026-06-05DeMichiei RobertBuy11.26K$8.7398.30K
2026-06-05LUMSDAINE ALFREDBuy10.00K$8.8188.10K
2026-04-01Bulgarelli Peter J.Buy14.23K——
2026-04-01Havdala EllenBuy14.23K——
2026-04-01Sotir Mark RBuy14.23K——
2026-04-01Sen RahulBuy14.23K——
2026-04-01Webb Robert ThomasBuy14.23K——
2026-04-01Robinson EdmondoBuy14.23K——
2026-04-01DeMichiei RobertBuy14.23K——
2026-04-01GOODYEAR WILLIAM MBuy14.23K——
2026-04-01Campion SuzanneBuy14.23K——
2026-04-01BYNOE PETER C BBuy14.23K——
2026-04-01Caspers DaveBuy35.67K——
2026-04-01Caspers DaveSell2.68K$8.6723.27K
2026-04-01Petrovich Stephen C.Buy24.90K——
2026-04-01Petrovich Stephen C.Sell1.81K$8.6715.68K
2026-04-01Byers David RaynorBuy11.54K——
2026-04-01Byers David RaynorSell924$8.678.01K
2026-04-01LUMSDAINE ALFREDBuy53.85K——
2026-04-01LUMSDAINE ALFREDSell4.38K$8.6737.98K
2026-04-01Bonick MartinBuy134.62K——
2026-04-01Bonick MartinSell10.95K$8.6794.95K
2026-03-31Petrovich Stephen C.Sell1.43K$8.5612.20K
2026-03-31Byers David RaynorSell819$8.567.01K
2026-03-31LUMSDAINE ALFREDSell2.51K$8.5621.49K
2026-03-31Bonick MartinSell8.03K$8.5668.70K
2026-03-11Petrovich Stephen C.Buy34.73K——
2026-03-11LUMSDAINE ALFREDBuy61.08K——
2026-03-11Chernin EthanBuy32.41K——
2026-03-11Bonick MartinBuy195.32K——
2026-03-11Byers David RaynorBuy8.86K——
2025-09-25LUMSDAINE ALFREDSell3.39K$13.1944.70K
2025-09-25Petrovich Stephen C.Sell788$13.1910.39K
2025-09-25Byers David RaynorSell524$13.196.91K
2025-04-02DeMichiei RobertBuy10.07K——
2025-04-02DeMichiei RobertOther0——
2025-04-01Caspers DaveBuy33.06K——
2025-04-01Caspers DaveBuy7.71K——
2025-04-01Caspers DaveSell2.48K$12.9732.17K
2025-04-01Byers David RaynorBuy11.56K——
2025-04-01Chernin EthanBuy20.91K——
2025-04-01Schultz DavidBuy26.98K——
2025-04-01Petrovich Stephen C.Buy22.26K——
2025-04-01LUMSDAINE ALFREDBuy53.97K——
2025-04-01Bonick MartinBuy134.93K——
2025-03-31Caspers DaveOther0——
2025-03-31Byers David RaynorSell676$13.759.29K
2025-03-31Chernin EthanSell1.33K$13.7518.32K
2025-03-31Schultz DavidSell1.82K$13.7525.09K
2025-03-31Petrovich Stephen C.Sell1.43K$13.7519.64K
2025-03-31LUMSDAINE ALFREDSell2.51K$13.7534.51K
2025-03-31Bonick MartinSell12.97K$13.75178.34K
2025-03-21Campion SuzanneBuy12.92K——
2025-03-21BYNOE PETER C BBuy12.92K——
2025-03-21GOODYEAR WILLIAM MBuy12.92K——
2025-03-21Havdala EllenBuy12.92K——
2025-03-21Sen RahulBuy12.92K——
2025-03-21Sotir Mark RBuy12.92K——
2025-03-21Robinson EdmondoBuy12.92K——
2025-03-21Webb Robert ThomasBuy12.92K——
2024-12-12Webb Robert ThomasBuy10.79K——
2024-12-12Robinson EdmondoBuy10.79K——
2024-12-12Havdala EllenBuy10.79K——
2024-12-12BYNOE PETER C BBuy10.79K——
2024-12-12Campion SuzanneBuy10.79K——
2024-12-12GOODYEAR WILLIAM MBuy10.79K——
2024-11-08Webb Robert ThomasBuy10.00K$16.49164.90K
2024-11-08Webb Robert ThomasBuy10.00K$17.47174.70K
2024-09-25Petrovich Stephen C.Buy9.70K——
2024-09-25LUMSDAINE ALFREDBuy41.74K——
2024-09-25Schultz DavidBuy16.54K——
2024-09-25Byers David RaynorBuy6.45K——
2024-07-18Petrovich Stephen C.Buy17.58K——
2024-07-18Webb Robert ThomasBuy11.56K——
2024-07-18Sotir Mark RBuy11.56K——
2024-07-18Sen RahulBuy11.56K——
2024-07-18Robinson EdmondoBuy11.56K——
2024-07-18Havdala EllenBuy11.56K——
2024-07-18GOODYEAR WILLIAM MBuy11.56K——
2024-07-18Campion SuzanneBuy11.56K——
2024-07-18BYNOE PETER C BBuy11.56K——
2024-07-18Schultz DavidBuy22.48K——
2024-07-18LUMSDAINE ALFREDBuy30.92K——
2024-07-18Chernin EthanBuy16.41K——
2024-07-18Byers David RaynorBuy8.33K——
2024-07-18Bonick MartinBuy98.88K——
2024-07-17Pure Health Capital Americas 1 SPV RSC LTDOther0——
2024-07-17Petrovich Stephen C.Other0——
2024-07-17Petrovich Stephen C.Other0——
2024-07-17BYNOE PETER C BOther0——
2024-07-17Byers David RaynorOther0——
2024-07-17LUMSDAINE ALFREDOther0——
2024-07-17Schultz DavidOther0——
2024-07-17Bonick MartinOther0——
2024-07-17Campion SuzanneOther0——
2024-07-17GOODYEAR WILLIAM MOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 142, holders +5 vs prior quarter. Ownership 76.69%.

HolderSharesChangeChange %Value
CHAI TRUST CO LLC77.25M00.00%760.11M
VENTAS, INC.9.34M00.00%91.93M
BLACKROCK, INC.2.18M418.13K+23.78%21.42M
AMERIPRISE FINANCIAL INC2.11M333.87K+18.79%20.77M
GOLDENTREE ASSET MANAGEMENT LP1.58M-722.69K-31.38%15.53M
AQR CAPITAL MANAGEMENT LLC1.45M505.46K+53.64%14.25M
CASTLEKNIGHT MANAGEMENT LP1.08M00.00%10.60M
VANGUARD CAPITAL MANAGEMENT LLC963.83K-44.60K-4.42%9.48M
BRIDGEWAY CAPITAL MANAGEMENT, LLC841.13K-89.54K-9.62%8.28M
GEODE CAPITAL MANAGEMENT, LLC620.95K59.50K+10.60%6.11M
ALGERT GLOBAL LLC597.75K554.35K+1277.29%5.88M
STATE STREET CORP566.21K-19.85K-3.39%5.57M
FIRST TRUST ADVISORS LP562.28K83.48K+17.44%5.53M
EMPOWERED FUNDS, LLC551.29K15.46K+2.88%5.42M
SAGEVIEW ADVISORY GROUP, LLC480.45K-160.15K-25.00%4.73M
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC444.90K2.30K+0.52%4.38M
UBS GROUP AG442.62K-8.06K-1.79%4.36M
BANK OF AMERICA CORP /DE/390.24K29.20K+8.09%3.84M
WEDGE CAPITAL MANAGEMENT L L P/NC327.24K222.45K+212.27%3.22M
MORGAN STANLEY315.96K23.93K+8.19%3.11M
AMERICAN CENTURY COMPANIES INC309.36K254.17K+460.51%3.04M
GOLDMAN SACHS GROUP INC304.45K85.44K+39.01%3.00M
JANE STREET GROUP, LLC300.34K106.32K+54.80%2.96M
JPMORGAN CHASE & CO242.33K73.72K+43.72%2.41M
BANK OF NEW YORK MELLON CORP241.59K535+0.22%2.38M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Ardent Health (ARDT) Stock Price & Analysis

ARDT$12.22+0.29 +2.47%

$1.72B

Market Cap

22.31

P/E

12.80

Forward P/E

44

Score

Price History